MAPT and early-onset autosomal dominant Alzheimer disease: A recent study found that preoperative plasma concentrations of phosphorylated tau at threonine 217 (tau-PT217) and 181 (tau-PT181), two Alzheimer’s disease biomarkers, are associated with POD and can serve as predictive biomarkers (5).